| mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.34 |
0.04 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.04 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.05 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.05 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.05 |
| mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.05 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.05 |